AI-Powered Cancer Diagnostics Firm Targets $400M IPO

By Tom Zanki · June 9, 2025, 4:24 PM EDT

Caris Life Sciences Inc., a developer of artificial-intelligence enhanced cancer diagnostic tests, on Monday launched plans for an estimated $400 million initial public offering, represented by Latham & Watkins LLP and...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login